Prognosis of 600 consecutive patients with hepatocellular carcinoma was analyzed in relation to treatment. They were divided into three stages based on four parameters of advanced disease: ascites, tumor greater than 50% of the two-dimensional size of the liver, serum albumin below 3 gm per dl, and
Primary hepatocellular carcinoma
β Scribed by Chong-Jin Oon; Michael A. Friedman
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 477 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
β¦ Synopsis
Primary hepatocellular cancer is a common and virulent malignancy found all over the world. New insights into this disease are being provided by evaluation of the impact of epidemiologic data (hepatitis viral exposure, race, sex, HLA typing, and environmental factors). An enhanced appreciation of the biochemical modulators of hepatocellular cancer metabolism is now also possible. The limited success of current therapies is far from satisfactory, but prospects for the future seem more varied and promising than ever before.
π SIMILAR VOLUMES
From the Section of Medical Oncology, Department of Medicine (N.E.), Section of Digestive Diseases, Department of Medicine (D.J.), Department of Surgery (S.B.), and Department of Radiotherapy (K.K.), Rush-Presbyterian-St.Luke's Medical Center, Chicago.